| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Royalty Pharma plc | EVP & Vice Chairman | Class A Ordinary Shares | 659K | $23.2M | $35.28 | Nov 5, 2025 | By SCH Investment Partners LLC |
| Royalty Pharma plc | EVP & Vice Chairman | Class A Ordinary Shares | 70K | $2.47M | $35.28 | Nov 5, 2025 | Direct |
| Royalty Pharma plc | EVP & Vice Chairman | Class E Ordinary Shares | 1.24M | May 16, 2025 | Indirect | ||
| Royalty Pharma plc | EVP & Vice Chairman | LP interests in RPI US Partners 2019, LP | 86.6K | Feb 14, 2025 | By SCH Investment Partners LLC | ||
| ACCELERON PHARMA INC | Director | Common Stock | 0 | $175.00 | Nov 19, 2021 | Direct | |
| ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | Nov 5, 2025 | 1 | $0 | 4 | Nov 7, 2025 | EVP & Vice Chairman |
| RPRX | Royalty Pharma plc | Aug 6, 2025 | 1 | $0 | 4 | Aug 8, 2025 | EVP & Vice Chairman |
| RPRX | Royalty Pharma plc | May 16, 2025 | 1 | $0 | 4 | May 20, 2025 | EVP & Vice Chairman |
| RPRX | Royalty Pharma plc | May 8, 2025 | 1 | $0 | 4 | May 9, 2025 | EVP & Vice Chairman |
| RPRX | Royalty Pharma plc | Feb 14, 2025 | 2 | $0 | 4 | Feb 18, 2025 | EVP & Vice Chairman |
| RPRX | Royalty Pharma plc | May 13, 2024 | 2 | $0 | 4 | May 16, 2024 | EVP & Vice Chairman |
| XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 3 | $0 | 4 | Nov 22, 2021 | Director |